Project Grant R01AI191447
Award Date
5/1/25
Completion Date
4/30/30
Dollars Obligated
$738K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Missouri, USA
Similar Awards
This $195,894 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University in St. Louis. The grant will fund a 5-year research project to study the mechanisms contributing to T cell dysregulation in STAT3 gain-of-function syndrome, a primary immune regulatory disorder. The research aims to gain a deeper understanding of critical interactions between T and B...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $649,053 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Washington University in St. Louis to investigate the role of the Ly49 family of receptors on CD8 T cells. The research aims to understand the functional contribution of these receptors to CD8 regulatory T cells (Tregs) and their potential relationship to interleukin-15 signaling and the transcription factor Helios. This effort...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $197,366 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University in St. Louis to conduct research aimed at understanding the mechanisms by which the human immune system naturally restricts a specific subset of HIV, known as X4-tropic virus. The key goals of the 5-year research project are to: (1) characterize the molecular mechanisms driving the restriction of...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $138,051 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Regents of the University of Minnesota, Office of Sponsored Projects Administration. The objective of this 2-year research project is to understand the role of thymic B cells in T cell tolerance and autoimmune disease pathogenesis. The research aims to investigate how type-III interferon drives thymic B cell licensing...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $246,623 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to New York University School of Medicine to conduct research on the molecular control of tolerogenic dendritic cell function. The research aims to pinpoint the specific dendritic cell subset responsible for regulating immune tolerance, characterize the molecular basis including aberrant cytokine production and signaling impairment, and...
The University of Chicago was awarded a $884,454 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant, awarded on June 6, 2024, supports research to perform clonal analysis of naturally occurring IL-10-producing TR1 regulatory T cells in mice. The objectives are to define the T cell receptor (TCR) repertoire, reactivity, differentiation trajectory, and transcriptional profile of...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the Regents of the University of Minnesota in the amount of $1,189,919.00 from July 1, 2024 to May 31, 2029. The grant will fund research to investigate the role of innate immune activation in the thymus and its impact on T cell tolerance and selection, particularly in relation to induced immune states such as inflammation, wound repair, and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant totaling $709,019 to the Benaroya Research Institute at Virginia Mason under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award supports research to investigate the role of the FOXP3 isoform in regulatory T cell function and its potential contribution to the development of systemic lupus erythematosus (SLE). The research aims to provide insights into the relationship between FOXP3...
This $2,483,910 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support three integrated projects at The Washington University focused on defining novel disease mechanisms related to genetic errors of immunity (GEIs). The first project will map genes prone to autosomal random monoallelic expression (ARMAE) in the immune system and evaluate the epigenetic regulation of this...
This federal Project Grant award, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), is funding a $264,750 research initiative at the University of Washington. The project, titled "Integrin-Mediated Regulation of Type-1 Dendritic Cell Positioning and Function in Lymph Nodes," aims to elucidate the role of the CD11a integrin in regulating the positioning and cell-cell interactions of...